Tekeda Pharmaceutical has agreed to pay approximately $2.4 billion to settle 9,000 Actos lawsuits across the county. The Locks Law Firm represents a number of clients involved in the litigation and is pleased to announce that Takeda has agreed to compensate thousands of bladder cancer victims and their families.
By way of background, Actos is a dangerous pharmaceutical intended to help diabetics manage their condition, but instead has been shown to cause bladder cancer. Even prior to the approval of Actos, premarket studies showed that bladder tumors had developed in animals. In the May 2012 issue of the British Medical Journal, researchers studied 115,727 patients and discovered that Actos ingestion increased the risk of contracting bladder cancer by 83 percent.
